Cite
HARVARD Citation
Di Cristo, V. et al. (2020). 96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation. HIV research & clinical practice. 21 (1), pp. 34-43. [Online].